Profiling Circulating miRNAs from the Plasma of Individuals with Metabolic Syndrome.
Sign Up to like & getrecommendations! Published in 2017 at "Methods in molecular biology"
DOI: 10.1007/978-1-4939-6524-3_13
Abstract: The technique of RT-qPCR (real time-quantitative polymerase chain reaction) is invaluable in miRNA research both at the profiling and individual RT-qPCR stages. At the profiling stage, numerous miRNAs are looked at in the plasma of… read more here.
Keywords: plasma individuals; circulating mirnas; individuals metabolic; metabolic syndrome ... See more keywords
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
Sign Up to like & getrecommendations! Published in 2019 at "Leukemia"
DOI: 10.1038/s41375-019-0588-4
Abstract: The reason why a few myeloma cells egress from the bone marrow (BM) into peripheral blood (PB) remains unknown. Here, we investigated molecular hallmarks of circulating tumor cells (CTCs) to identify the events leading to… read more here.
Keywords: transcriptional profiling; tumor cells; circulating tumor; cells multiple ... See more keywords
Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with metastatic breast cancer (mBC).
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.1016
Abstract: 1016Background: Clonal evolution during progression to and treatment of mBC highlights the importance of genomic profiling of recent samples to guide clinical decision making. We undertook this study to characterize genomic alterations (GA) in ctDNA… read more here.
Keywords: profiling; ctdna; mbc; genomic profiling ... See more keywords
Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.7_suppl.26
Abstract: 26Background: Ipilimumab (Ipi) is a humanized CTLA-4 antibody that blocks binding of CTLA-4 to B7, permitting T cell activation through CD28. Phased in Ipi added to chemotherapy (C) may enhance eff... read more here.
Keywords: chemotherapy; circulating cells; cell; cells tils ... See more keywords